The Xuhui Manufacturing Facility accommodates two independent production lines, comprising six 2,000L and four 500L single-use bioreactors for a total of 14,000L, along with ancillary purification equipment. Our second manufacturing facility in Shanghai, the Songjiang Manufacturing Facility, can manufacture over 20 products simultaneously when fully operated. It strictly follows international GMP standards, adopts new technologies to ensure quality and reduce cost, meets the international level of biomedical automation, informatization, and intelligence (Pharmaceutical Industry 4.0) and features low carbon, energy conservation and eco-protection.
We are a pioneer in adopting single-use technologies in China, particularly single-use bioreactors. Single-use bioreactors are estimated to generally reduce capital expenditure by up to 50% and production costs by up to 25% to 30%, and spare the efforts for clean-up and disinfection after each production cycle, which reduces per-batch production time and decreases the risk of contamination. In addition, we strive to achieve further cost efficiency through our focus on developing continuous process technologies in-house (instead of standard batch feeding process), which we expect will enable us to significantly reduce per-unit manufacturing costs and reduce liquid and solid wastes pollution, while at the same time significantly increasing productivity.